Similar articles for PMID: 15734288

Year	Number of Results
1965	1
1966	1
1968	1
1969	1
1970	2
1972	1
1973	3
1974	1
1976	1
1985	1
1988	1
1991	1
1993	1
1994	1
1995	2
1996	1
1997	1
1998	3
1999	3
2000	4
2001	5
2002	3
2003	4
2004	4
2005	11
2006	6
2007	11
2008	10
2009	14
2010	5
2011	2
2012	2
2013	1
2014	3
2016	1
2017	1
2018	4
2019	1
2022	1
2023	2
2024	0

1

Does the determination of the Bb vitamin D receptor genotype identify psoriasis vulgaris patients responsive to topical tacalcitol?

Giomi B, Ruggiero M, Fabbri P, Gulisano M, Peruzzi B, Caproni M, Pacini S. Giomi B, et al. J Dermatol Sci. 2005 Mar;37(3):180-1. doi: 10.1016/j.jdermsci.2004.11.008. Epub 2005 Jan 6. J Dermatol Sci. 2005. PMID: 15734288 No abstract available.

2

Clinical evaluation of topical tacalcitol efficacy in extending the remission period between nb-UVB phototherapy cycles in psoriatic patients.

Prignano F, Buggiani G, Lotti T. Prignano F, et al. Acta Biomed. 2009 Apr;80(1):51-6. Acta Biomed. 2009. PMID: 19705621

3

Profile of clinical efficacy and safety of topical tacalcitol.

Leone G, Pacifico A. Leone G, et al. Acta Biomed. 2005 Apr;76(1):13-9. Acta Biomed. 2005. PMID: 16116820 Review.

4

Tacalcitol ointment for the treatment of nail psoriasis.

Márquez Balbás G, Sánchez Regaña M, Umbert Millet P. Márquez Balbás G, et al. J Dermatolog Treat. 2009;20(5):308-10. doi: 10.1080/09546630902787585. J Dermatolog Treat. 2009. PMID: 19367480 Clinical Trial.

5

Tacalcitol in the treatment of psoriasis vulgaris: the Spanish experience.

Lecha M, Mirada A, López S, Artés M; T.O.P. Research Group. Lecha M, et al. J Eur Acad Dermatol Venereol. 2005 Jul;19(4):414-7. doi: 10.1111/j.1468-3083.2005.01099.x. J Eur Acad Dermatol Venereol. 2005. PMID: 15987284 Clinical Trial.

6

Four cases of sebopsoriasis or seborrheic dermatitis of the face and scalp successfully treated with 1a-24 (R)-dihydroxycholecalciferol (tacalcitol) cream.

Nakayama J. Nakayama J. Eur J Dermatol. 2000 Oct-Nov;10(7):528-32. Eur J Dermatol. 2000. PMID: 11056423

7

Open trial of topical tacalcitol [1 alpha 24(OH)2D3] and solar irradiation for vitiligo vulgaris: upregulation of c-Kit mRNA by cultured melanocytes.

Katayama I, Ashida M, Maeda A, Eishi K, Murota H, Bae SJ. Katayama I, et al. Eur J Dermatol. 2003 Jul-Aug;13(4):372-6. Eur J Dermatol. 2003. PMID: 12948918 Clinical Trial.

8

Polymorphisms of vitamin D receptor gene in Japanese patients with psoriasis vulgaris.

Saeki H, Asano N, Tsunemi Y, Takekoshi T, Kishimoto M, Mitsui H, Tada Y, Torii H, Komine M, Asahina A, Tamaki K. Saeki H, et al. J Dermatol Sci. 2002 Nov;30(2):167-71. doi: 10.1016/s0923-1811(02)00073-7. J Dermatol Sci. 2002. PMID: 12413773

9

Topical tacalcitol treatment for psoriasis.

Harrison PV. Harrison PV. Hosp Med. 2000 Jun;61(6):402-5. doi: 10.12968/hosp.2000.61.6.1355. Hosp Med. 2000. PMID: 10962655 Review.

10

High-concentration (20 μg g⁻¹ ) tacalcitol ointment in the treatment of facial psoriasis: an 8-week open-label clinical trial.

Choi JW, Choi JW, Kwon IH, Youn JI. Choi JW, et al. Br J Dermatol. 2010 Jun;162(6):1359-64. doi: 10.1111/j.1365-2133.2010.09758.x. Epub 2010 Mar 10. Br J Dermatol. 2010. PMID: 20302582 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

119 results

Results by year